Načítá se...
Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma
BACKGROUND: Body composition is minimally investigated in an immunotherapy era. Specific body composition signals such as myosteatosis may reflect aspects of patients' immunology and thereby their ability to respond to immunotherapies. Ipilimumab is a key checkpoint inhibitor in metastatic mela...
Uloženo v:
| Vydáno v: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296257/ https://ncbi.nlm.nih.gov/pubmed/32053287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12538 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|